Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L O Neville

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|February 7, 1987
Teicoplanin-resistant coagulase-negative staphylococciW Brumeitt, J M Hamilton-Miller, L O Neville
International Journal of Antimicrobial Agents|May 1, 1995
Teicoplanin vs. vancomycin for the treatment of serious infections: a randomised trialL O Neville, W Brumfitt, J M Hamilton-Miller, et al.
Lancet (London, England)|March 23, 1985
C-reactive protein and liver viability after transplantationG W Smith, P Eggleton, C C Kibbler, et al.
Lancet (London, England)|August 24, 1991
Methicillin resistant Staphylococcus aureus without clumping factor, protein A, and DNAseL O Neville, O J Billington, C C Kibbler, et al.
Journal of the Royal Society of Medicine|July 1, 1994
Yersinia pseudotuberculosis in a 3 year old and rapid response to cefotaximeS J Nesbitt, L O Neville, F R Scott, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1988
Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysisL O Neville, R A Baillod, W Brumfitt, et al.
International Journal of Clinical Pharmacology Research|January 1, 1987
Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspectsL O Neville, R Baillod, D Grady, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|February 7, 1987
Teicoplanin-resistant coagulase-negative staphylococciW Brumeitt, J M Hamilton-Miller, L O Neville
International Journal of Antimicrobial Agents|May 1, 1995
Teicoplanin vs. vancomycin for the treatment of serious infections: a randomised trialL O Neville, W Brumfitt, J M Hamilton-Miller, et al.
Lancet (London, England)|March 23, 1985
C-reactive protein and liver viability after transplantationG W Smith, P Eggleton, C C Kibbler, et al.
Lancet (London, England)|August 24, 1991
Methicillin resistant Staphylococcus aureus without clumping factor, protein A, and DNAseL O Neville, O J Billington, C C Kibbler, et al.
Journal of the Royal Society of Medicine|July 1, 1994
Yersinia pseudotuberculosis in a 3 year old and rapid response to cefotaximeS J Nesbitt, L O Neville, F R Scott, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1988
Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysisL O Neville, R A Baillod, W Brumfitt, et al.
International Journal of Clinical Pharmacology Research|January 1, 1987
Teicoplanin in patients with chronic renal failure on dialysis: microbiological and pharmacokinetic aspectsL O Neville, R Baillod, D Grady, et al.
Pageof 1